CAREMARK RX INC·4

Feb 16, 8:05 PM ET

CAREMARK RX INC 4

4 · CAREMARK RX INC · Filed Feb 16, 2005

Insider Transaction Report

Form 4
Period: 2005-02-14
Transactions
  • Award

    Stock Units

    2005-02-14$39.79/sh+2,023.12$80,5002,023.12 total
    Common Stock, par value $.001 (2,023.12 underlying)
Holdings
  • Common Stock, par value $.001

    6,000
  • Stock Units

    Common Stock, par value $.001 (1,680.3 underlying)
    1,680.3
  • Stock Units

    Common Stock, par value $.001 (203.65 underlying)
    203.65
  • Stock Units

    Common Stock, par value $.001 (280.44 underlying)
    280.44
  • Stock Units

    Common Stock, par value $.001 (1,746.712 underlying)
    1,746.712
  • Stock Option

    Exercise: $25.14From: 2004-01-02Exp: 2014-01-02Common Stock, par value $.001 (25,000 underlying)
    25,000
  • Stock Units

    Common Stock, par value $.001 (3,165.254 underlying)
    3,165.254
Footnotes (2)
  • [F1]34% of these options are exercisable on the grant date, and 33% are exercisable on each of the 1st and 2nd anniversaries of the grant date.
  • [F2]These stock units were accrued under the Caremark Rx, Inc. Director Deferred Compensation Plan, pursuant to which the reporting person has deferred an annual retainer and/or meeting fees. The reporting person may elect payment of the stock units in the form of a lump sum payment of Caremark Rx, Inc. common stock no earlier than 4 years after the last day of the calendar year in which the compensation attributable to the stock unit was deferred. Payment will be made within a reasonably practicable period of time following the earlier of a change of control (as defined in the plan) or the cessation of the reporting person's status as a non-employee member of Caremark Rx, Inc.'s Board of Directors.

Documents

1 file
  • 4
    rrd69353.xmlPrimary